GlassScriptPhysician profile
Bradley James Centala
NPI 1194477075
$6,409.20
in general payments reported to CMS, 2019-2025
33 companies · $578 in 2025
The $578 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $877 · 2023: $2,094 · 2024: $2,859 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,531.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $883.85 | 2022-2025 | |
| Novo Nordisk INC | $604.61 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $576.48 | 2022-2024 | Caplyta |
| Pfizer INC. | $500.76 | 2023-2025 | |
| Glaxosmithkline, LLC. | $437.31 | 2022-2024 | Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $392.58 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Otsuka America Pharmaceutical, INC. | $351.62 | 2022-2025 | Rexulti |
| Amgen INC. | $342.64 | 2023-2025 | Otezla, Repatha, Otezla |
| Lundbeck LLC | $231.71 | 2022-2025 | Rexulti |
| Axsome Therapeutics, INC. | $222.99 | 2022-2024 | Auvelity |
| Lilly USA, LLC | $210.95 | 2024 | Zepbound, Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $199.66 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $191.24 | 2022-2025 | Trintellix |
| Teva Pharmaceuticals USA, INC. | $166.93 | 2022-2024 | Austedo Xr, Austedo, Ajovy |
| Alkermes, INC. | $148.76 | 2022-2024 | Aristada, Vivitrol, Lybalvi |
Show all 33 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Centala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.